PET Study of Cerebral Metabolism of 11C-acetoacetate and 18F-FDG in Patients Under Moderate Ketosis (TEP-KD)

Université de Sherbrooke

Status: Completed

Conditions: Healthy

Treatments: Dietary Supplement: Post-KD; Dietary Supplement: Pre-KD

Study type: Interventional

Funder types: Other

Identifiers

NCT02409784

13-214

Details and patient eligibility

About

Regional brain glucose hypometabolism occurs during aging and may contribute to the onset of aging-related cognitive impairment in humans. Ketones are the main alternative energy substrate to glucose for the brain. Several studies show that brain ketone uptake and metabolism are unaltered in cognitively-normal older persons and in Alzheimer's disease (AD). Nutritional ketosis is reported to have a positive impact on cognitive performances in mild cognitive impairment and AD. Nevertheless, changes in regional brain glucose and ketone uptake in adults are poorly understood during diet-induced experimental ketosis. The investigators hypothesis was that during diet-induced ketosis, brain ketone uptake would be directly correlated with the elevation of blood ketone levels and inversely correlated to brain glucose uptake.

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy adults
• No signs of cognitive impairment

Exclusion criteria

• Not within the age limits
• Pregnancy or breast feeding
• Incapacity to withstand a supine position for 40 min
• Non lacunar infarction
• Known psychiatric history of schizophrenia, psychotic disorders, major affective disorders (bipolar disorder and major depression <5 years), panic disorder, obsessive compulsive disorders and other conditions that may affect memory
• Epilepsy, brain trauma with loss of consciousness, subarachnoid hemorrhage
• History of alcool and/or substances abuse (excessive alcool consumption ≥10 drinks/weeks)
• Parkinson disease
• Down syndrome
• Inflammatory disease
• Abnormal blood pressure, liver or kidney function, blood count
• Dyslipidemia, hypothyroidism, osteoporosis
• Presence of a metal object in the body

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

Ketogenic diet

Experimental group

Description:

Pre/Post TEP study with a 4 days ketogenic diet (KD). Interventions 1: Pre-KD = Participants did a TEP before starting the 4-day diet Intervention 2: Post-KD = Participants did a TEP after completing the 4-day diet

Treatment:

Dietary Supplement: Post-KD

Dietary Supplement: Pre-KD